Feature|Articles|December 10, 2023
- Pharmaceutical Executive: December 2023
- Volume 43
- Issue 12
Pharmaceutical Executive: December 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Finding that Sparkalmost 2 years ago
Remote Reliance: The Rise of Oncology Home Carealmost 2 years ago
It’s Always Important to Remember: Leaders Make Mistakesalmost 2 years ago
Will Calendar Change Bring an End to Run of Volatility in Biotech?almost 2 years ago
FDA, Industry Face Challenges in the Year Aheadalmost 2 years ago
Navigating the Future: Key Market Access Trends to Watch in ’24almost 2 years ago
Reflecting on 2023Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Stock Becomes UK’s Biggest Stock
2
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
3
Basel, Switzerland, Puts Out Call for Pharma Execs
4
HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research
5
